Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

EndpointsView source article

Part of story

Takeda R&D chief Andy Plump to retire in June 2027

Andy Plump, who led Takeda's research and development overhaul and pushed the company toward biotech partnerships, will retire in June 2027 after celebrating two recent FDA approvals.

Sep 10, 20262 sourcesPharmaceutical Industry FDA drug approval

Takeda R&D chief Andy Plump to retire in June 2027

Other sources for this story

BioPharma Dive

Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

Part of story

Takeda R&D chief Andy Plump to retire in June 2027

Other sources for this story

Andy Plump, architect of Takeda’s R&D overhaul, to retire next year

Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research head

Part of story

Takeda R&D chief Andy Plump to retire in June 2027

Other sources for this story

Andy Plump, architect of Takeda’s R&D overhaul, to retire next year